Cargando…
Differences in COVID-19 screening, diagnosis, and hospitalization rates among US pregnant women with and without a substance use disorder
Autores principales: | Gao, Yitong (Alice), Jarlenski, Marian P., Chen, Qingwen, Krans, Elizabeth E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184873/ https://www.ncbi.nlm.nih.gov/pubmed/34116037 http://dx.doi.org/10.1016/j.ajog.2021.06.004 |
Ejemplares similares
-
Association of Duration of Methadone or Buprenorphine Use During Pregnancy With Risk of Nonfatal Drug Overdose Among Pregnant Persons With Opioid Use Disorder in the US
por: Jarlenski, Marian, et al.
Publicado: (2022) -
Sex-related differences in the prevalence of substance use disorders, treatment, and overdose among parents with young children
por: Gao, Yitong (Alice), et al.
Publicado: (2023) -
Association of Race With Urine Toxicology Testing Among Pregnant Patients During Labor and Delivery
por: Jarlenski, Marian, et al.
Publicado: (2023) -
Market Share of US Catholic Hospitals and Associated Geographic Network Access to Reproductive Health Services
por: Drake, Coleman, et al.
Publicado: (2020) -
Cluster analysis to identify patient profiles and substance use patterns among pregnant persons with opioid use disorder
por: Charron, Elizabeth, et al.
Publicado: (2023)